Showing results (431-440 of 2,106) with videos related to
Sort By:
Pageof 211
CNS Drugs|December 8, 2005
Tick-borne encephalopathies : epidemiology, diagnosis, treatment and preventionGöran Günther, Mats HaglundCNS Drugs|August 20, 2016
The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 YearsMark Zimmerman, Carolina Guzman Holst, Heather L Clark, et al.CNS Drugs|August 4, 2018
Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache DisordersMichael J Marmura, Aliza S KumpinskyCNS Drugs|August 3, 2018
Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm AnalysisDimitrios Papadopoulos, Dimos-Dimitrios D MitsikostasCNS Drugs|February 17, 2010
Gene therapy in Parkinson's disease: rationale and current statusLi Rebekah Feng, Kathleen A Maguire-ZeissCNS Drugs|February 17, 2010
Olanzapine/fluoxetine: a review of its use in patients with treatment-resistant major depressive disorderJamie D Croxtall, Lesley J ScottCNS Drugs|June 4, 2017
A Review of Adjunctive CNS Medications Used for the Treatment of Post-Surgical PainAjit Rai, Howard Meng, Aliza Weinrib, et al.CNS Drugs|June 22, 2017
Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's DiseaseYanwei Li, Jinying Zhao, Christian HölscherCNS Drugs|December 5, 2009
Role of infection in the pathogenesis of Alzheimer's disease: implications for treatmentClive Holmes, Darren CotterellPageof 211